ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
First US Service Members Treated with the Only FDA-Approved Cross-Linking Procedure in the U.S.
January 16, 2017Avedro, Inc., an ophthalmic pharmaceutical and medical device company, has begun selling Photrexa Viscous® (riboflavin 5-‘phosphate in 20% dextran ophthalmic solution), Photrexa® (riboflavin 5’-phosphate ophthalmic solution) and the KXL® System to key mil
Pharma Sources Insight January 2025
